Trial to Evaluate Efficacy and Safety of LIB003, Evolocumab and Alirocumab in High-risk CVD Patients
Clinical trial NCT04790513 · COMPLETED
Trial details
- NCT number
- NCT04790513
- Sponsor
- LIB Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-22
- Primary completion
- 2022-09-30
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.